ADHD

Updated 13 June 2017

No Link between oxytocin-assisted birth and ADHD

A new study suggests that babies whose mothers received oxytocin during labour are not at a higher risk of developing ADHD.

0

If a woman giving birth stops progressing during labour, she might receive oxytocin (Syntometrin) as "augmentation." This drug is a synthetic version of the oxytocin hormone involved in birth. It helps push labour along, increasing the likelihood that the cervix will continue dilating. But the hormone may have other effects, too.

"Oxytocin has many functions, including affecting social interactions," said Dr. Glen Elliott, chief psychiatrist and medical director of Children's Health Council in Palo Alto, Calif. "Earlier studies were divided as to whether use of oxytocin to help labour progress increased the risk of the child later having a diagnosis of ADHD."

The original concern that ADHD and oxytocin might be linked arose from non-human studies, study author Mette Juhl explained.

"Animal studies have found that oxytocin is passed on from mother to foetus via the placental barrier, and that the foetal brain has been affected by exposure to oxytocin," said Juhl, an associate professor of midwifery at Metropolitan University College in Copenhagen, Denmark.

It was possible, she said, that oxytocin might have some direct effect on the brain of the baby being born.

Drug should be used with caution

"According to the U.S. Institute for Safe Medication Practices, oxytocin is a drug that should be used with caution," Juhl said. "In light of the extensive use of labour augmentation in healthy young women, it is important to find out if augmentation treatment is associated with adverse effects, such as ADHD."

Children with ADHD, a brain disorder, tend to be inattentive, impulsive and hyperactive. These symptoms can make it hard to succeed in school and get along with others.

Juhl's team looked at children who had received either an ADHD diagnosis or a prescription for an ADHD medication among more than 546,000 Danish mothers.

Then they compared the 26 percent of children born to mothers who received oxytocin for labour augmentation to the children of mothers who did not.

The results showed that 0.9 percent of the children exposed to oxytocin had been diagnosed with or treated for ADHD. Overall, however, children exposed to oxytocin were no more likely to have ADHD than those not exposed, the study found.

"One of the ongoing concerns physicians and parents alike have is that actions taken early on, especially during pregnancy and delivery, may cause unanticipated problems later on," said Elliott, who was not involved in the study. "But using a large registry of births, the authors found no evidence to support an increased risk of ADHD when oxytocin was used during labour."

Using very large groups, such as the half million mothers in this study, is important for research such as this because it's otherwise almost impossible to prove one thing is not linked to another, Elliott said.

This study's finding that ADHD and oxytocin augmentation are unrelated is even more important, he said, because past research has found that complicated deliveries are related to a higher risk of various developmental problems later on.

"This study, hopefully, will reassure the obstetrician and mother-to-be that if oxytocin seems appropriate to ease delivery, it will not lead to markedly higher risk of the child having ADHD later in life," Elliott said.

The study, published online Feb. 9 in Paediatrics, was funded by the Tryg Foundation and the Danish Medical Research Council. The authors reported no financial ties related to this research.

Read more:

ADHD linked to earlier use of elicit drugs in teens

Side effects of ADHD medication

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

ADHD Expert

Dr Renata Schoeman has been in full-time private practice as a general psychiatrist (child, adolescent and adult psychiatry) since 2008, currently based in Oude Westhof (Bellville). Renata also holds appointments as senior lecturer in Leadership (USB) and as a virtual faculty member of USB Executive Development’s Neuroleadership programme. She serves on the advisory boards of various pharmaceutical companies, as a director of the Psychiatric Management Group (PsychMG) and is the co-convenor of the South African Society of Psychiatrist (SASOP) special interest group for adult ADHD, and co-founder of the Goldilocks and The Bear Foundation (www.gb4adhd.co.za) She is passionate about corporate mental health awareness and uses her neuroscience background to assist leaders in equipping them to become balanced, healthy and dynamic leaders that take their own and their team’s emotional, intellectual, social health and physical needs into account. Renata is academically active and enjoys research and collaborative work, has published in many peer-reviewed journals, and has presented at local and international congresses. She is regularly invited to present at conferences and to engage with the media. During her post-graduate studies, she trained at Harvard, Boston in neurocognition and neuroimaging. Her awards include, amongst others, the Young Minds in Psychiatry award from the American Psychiatric Association, the Discovery Foundation Fellowship award, a Thuthuka award from the NRF, and a MRC Fellowship. She also received the Top MBA student award and the Director’s award from USB for 2015. She was a finalist for the Businesswomen’s Association of South Africa’s Businesswoman of the Year Award for 2016, and received the Excellence in Media Work award from SASOP during 2016.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules